​

HOOKIPA Pharma (HOOK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

HOOK Stock Forecast

HOOKIPA Pharma (HOOK) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $3.00 and a low of $3.00. This represents a 289.61% increase from the last price of $0.77.

- $1 $2 $3 $4 $5 $6 High: $3 Avg: $3 Low: $3 Last Closed Price: $0.77

HOOK Stock Rating

HOOKIPA Pharma stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 2 Hold (28.57%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 2 5 Strong Sell Sell Hold Buy Strong Buy

HOOK Price Target Upside V Benchmarks

TypeNameUpside
StockHOOKIPA Pharma289.61%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.77$0.77$0.77
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25112--4
Mar, 25112--4
Feb, 25112--4
Jan, 25112--4
Dec, 24311--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 11, 2022Leerink Partners$3.00$1.5988.68%289.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 10, 2025H.C. WainwrightBuyNeutraldowngrade
Aug 09, 2024JMP SecuritiesOutperformOutperformhold
Jun 05, 2024H.C. WainwrightBuyBuyhold
May 21, 2024RBC CapitalBuyBuyhold
May 21, 2024RBC CapitalOutperformOutperformhold
Nov 15, 2022RBC CapitalOutperformOutperformhold
Aug 11, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-16.90$-23.00$-9.90$-8.63$-3.47----
Avg Forecast$-18.15$-22.09$-10.63$-7.93$-2.10$-2.15$-1.44$-1.04$-1.23
High Forecast$-16.68$-20.30$-8.90$-6.46$-1.59$-1.64$-1.32$-0.83$-0.93
Low Forecast$-19.62$-23.88$-12.36$-9.00$-2.60$-2.67$-1.56$-1.25$-1.53
Surprise %-6.89%4.12%-6.87%8.83%65.24%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$19.58M$18.45M$14.25M$20.13M-----
Avg Forecast$17.96M$16.83M$19.10M$18.80M$43.07M$16.50M$10.50M$65.93M$163.01M
High Forecast$19.08M$17.89M$21.49M$19.15M$51.02M$19.55M$12.44M$78.10M$193.10M
Low Forecast$16.84M$15.79M$16.71M$18.46M$35.12M$13.45M$8.56M$53.76M$132.92M
Surprise %9.02%9.58%-25.40%7.04%-----

Net Income Forecast

$-250M $-200M $-150M $-100M $-50M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-44.08M$-75.67M$-64.92M$-81.58M$-43.50M----
Avg Forecast$-171.57M$-208.77M$-100.47M$-81.58M$-19.80M$-20.35M$-13.61M$-9.83M$-11.63M
High Forecast$-157.66M$-191.85M$-84.15M$-61.04M$-15.05M$-15.47M$-12.48M$-7.85M$-8.84M
Low Forecast$-185.49M$-225.71M$-116.79M$-85.09M$-24.56M$-25.24M$-14.75M$-11.82M$-14.42M
Surprise %-74.31%-63.76%-35.39%-119.68%----

HOOK Forecast FAQ

Is HOOKIPA Pharma stock a buy?

HOOKIPA Pharma stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that HOOKIPA Pharma is a favorable investment for most analysts.

What is HOOKIPA Pharma's price target?

HOOKIPA Pharma's price target, set by 7 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $3 at the low end to $3 at the high end, suggesting a potential 289.61% change from the previous closing price of $0.77.

How does HOOKIPA Pharma stock forecast compare to its benchmarks?

HOOKIPA Pharma's stock forecast shows a 289.61% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for HOOKIPA Pharma over the past three months?

  • April 2025: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 25.00% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is HOOKIPA Pharma’s EPS forecast?

HOOKIPA Pharma's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.15, marking a -38.04% decrease from the reported $-3.47 in 2024. Estimates for the following years are $-1.44 in 2026, $-1.04 in 2027, and $-1.23 in 2028.

What is HOOKIPA Pharma’s revenue forecast?

HOOKIPA Pharma's average annual revenue forecast for its fiscal year ending in December 2025 is $16.5M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $10.5M, followed by $65.93M for 2027, and $163.01M for 2028.

What is HOOKIPA Pharma’s net income forecast?

HOOKIPA Pharma's net income forecast for the fiscal year ending in December 2025 stands at $-20.355M, representing a -53.21% decrease from the reported $-43.503M in 2024. Projections indicate $-13.612M in 2026, $-9.831M in 2027, and $-11.627M in 2028.